SPL-IN-1

SPL-IN-1 (compound C17) is a dual species sphingosine-1-phosphate lyase inhibitor[1].

Product Specifications

CAS Number

[353770-24-8]

UNSPSC

12352005

Target

LPL Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/spl-in-1.html

Solubility

10 mM in DMSO

Smiles

CCCOC(C1=C(SC2=C1CCCCC2)NC(CCCC(NC3=C(C4=C(S3)CCCCC4)C(OCCC)=O)=O)=O)=O

Molecular Formula

C31H42N2O6S2

Molecular Weight

602.80

References & Citations

[1]Cellini B, et al. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study. Sci Rep. 2023;13 (1) :22692. Published 2023 Dec 20. |[2]Cellini B, et al. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study. Sci Rep. 2023;13 (1) :22692. Published 2023 Dec 20.